Importantly, this combination therapy regimen effectively reduced the levels of p‐STAT3, p‐AKT, and immunosuppression marker (ARG‐1 protein) (Fig 7E) and up‐regulated CD8 expression in adenocarcinoma lesions. This evidence concerns the gene AKT1 and adenocarcinoma.